[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Immuno-modulatory Biomaterial Market Report 2016

November 2016 | 106 pages | ID: UFB05854DF2EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Immuno-modulatory Biomaterial

Revenue, means the sales value of Immuno-modulatory Biomaterial

Revenue, means the salies sales (consumption) of Immuno-modulatory Biomaterial in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Biomet, Inc. (US)
  • Bioventus LLC (US)
  • DePuy Synthes Companies (US)
  • DePuy Spine, Inc. (US)
  • Exactech, Inc. (US)
  • Histogenics Corp. (US)
  • Integra LifeSciences Holdings Corp (US)
  • LifeCell Corporation (US)
  • LifeNet Health, Inc. (US)
  • Medtronic, Inc. (US)
  • NovaBone Products LLC (US)
  • NuVasive, Inc. (US)
  • Orthofix International N.V. (Netherlands)
  • Osiris Therapeutics, Inc. (US)
  • Smith & Nephew Plc (UK)
  • Stryker Corporation (US)
  • TiGenix N.V. (Belgium)
  • Wright Medical Technology, Inc. (US)
  • BioMimetic Therapeutics LLC (US)
  • Zimmer Holdings, Inc. (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Immuno-modulatory Biomaterial in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Immuno-modulatory Biomaterial Market Report 2016

1 IMMUNO-MODULATORY BIOMATERIAL OVERVIEW

1.1 Product Overview and Scope of Immuno-modulatory Biomaterial
1.2 Classification of Immuno-modulatory Biomaterial
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Immuno-modulatory Biomaterial
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Immuno-modulatory Biomaterial (2011-2021)
  1.4.1 United States Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2021)
  1.4.2 United States Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)

2 UNITED STATES IMMUNO-MODULATORY BIOMATERIAL COMPETITION BY MANUFACTURERS

2.1 United States Immuno-modulatory Biomaterial Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Immuno-modulatory Biomaterial Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Immuno-modulatory Biomaterial Average Price by Manufactures (2015 and 2016)
2.4 Immuno-modulatory Biomaterial Market Competitive Situation and Trends
  2.4.1 Immuno-modulatory Biomaterial Market Concentration Rate
  2.4.2 Immuno-modulatory Biomaterial Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES IMMUNO-MODULATORY BIOMATERIAL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Immuno-modulatory Biomaterial Sales and Market Share by Type (2011-2016)
3.2 United States Immuno-modulatory Biomaterial Revenue and Market Share by Type (2011-2016)
3.3 United States Immuno-modulatory Biomaterial Price by Type (2011-2016)
3.4 United States Immuno-modulatory Biomaterial Sales Growth Rate by Type (2011-2016)

4 UNITED STATES IMMUNO-MODULATORY BIOMATERIAL SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Immuno-modulatory Biomaterial Sales and Market Share by Application (2011-2016)
4.2 United States Immuno-modulatory Biomaterial Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES IMMUNO-MODULATORY BIOMATERIAL MANUFACTURERS PROFILES/ANALYSIS

5.1 Biomet, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bioventus LLC (US)
  5.2.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bioventus LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 DePuy Synthes Companies (US)
  5.3.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 DePuy Spine, Inc. (US)
  5.4.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Exactech, Inc. (US)
  5.5.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Histogenics Corp. (US)
  5.6.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Integra LifeSciences Holdings Corp (US)
  5.7.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 LifeCell Corporation (US)
  5.8.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 LifeNet Health, Inc. (US)
  5.9.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Medtronic, Inc. (US)
  5.10.2 Immuno-modulatory Biomaterial Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 NovaBone Products LLC (US)
5.12 NuVasive, Inc. (US)
5.13 Orthofix International N.V. (Netherlands)
5.14 Osiris Therapeutics, Inc. (US)
5.15 Smith & Nephew Plc (UK)
5.16 Stryker Corporation (US)
5.17 TiGenix N.V. (Belgium)
5.18 Wright Medical Technology, Inc. (US)
5.19 BioMimetic Therapeutics LLC (US)
5.20 Zimmer Holdings, Inc. (US)

6 IMMUNO-MODULATORY BIOMATERIAL MANUFACTURING COST ANALYSIS

6.1 Immuno-modulatory Biomaterial Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Immuno-modulatory Biomaterial

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Immuno-modulatory Biomaterial Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Immuno-modulatory Biomaterial Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES IMMUNO-MODULATORY BIOMATERIAL MARKET FORECAST (2016-2021)

10.1 United States Immuno-modulatory Biomaterial Sales, Revenue Forecast (2016-2021)
10.2 United States Immuno-modulatory Biomaterial Sales Forecast by Type (2016-2021)
10.3 United States Immuno-modulatory Biomaterial Sales Forecast by Application (2016-2021)
10.4 Immuno-modulatory Biomaterial Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Immuno-modulatory Biomaterial
Table Classification of Immuno-modulatory Biomaterial
Figure United States Sales Market Share of Immuno-modulatory Biomaterial by Type in 2015
Table Application of Immuno-modulatory Biomaterial
Figure United States Sales Market Share of Immuno-modulatory Biomaterial by Application in 2015
Figure United States Immuno-modulatory Biomaterial Sales and Growth Rate (2011-2021)
Figure United States Immuno-modulatory Biomaterial Revenue and Growth Rate (2011-2021)
Table United States Immuno-modulatory Biomaterial Sales of Key Manufacturers (2015 and 2016)
Table United States Immuno-modulatory Biomaterial Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Immuno-modulatory Biomaterial Sales Share by Manufacturers
Figure 2016 Immuno-modulatory Biomaterial Sales Share by Manufacturers
Table United States Immuno-modulatory Biomaterial Revenue by Manufacturers (2015 and 2016)
Table United States Immuno-modulatory Biomaterial Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Immuno-modulatory Biomaterial Revenue Share by Manufacturers
Table 2016 United States Immuno-modulatory Biomaterial Revenue Share by Manufacturers
Table United States Market Immuno-modulatory Biomaterial Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Immuno-modulatory Biomaterial Average Price of Key Manufacturers in 2015
Figure Immuno-modulatory Biomaterial Market Share of Top 3 Manufacturers
Figure Immuno-modulatory Biomaterial Market Share of Top 5 Manufacturers
Table United States Immuno-modulatory Biomaterial Sales by Type (2011-2016)
Table United States Immuno-modulatory Biomaterial Sales Share by Type (2011-2016)
Figure United States Immuno-modulatory Biomaterial Sales Market Share by Type in 2015
Table United States Immuno-modulatory Biomaterial Revenue and Market Share by Type (2011-2016)
Table United States Immuno-modulatory Biomaterial Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Immuno-modulatory Biomaterial by Type (2011-2016)
Table United States Immuno-modulatory Biomaterial Price by Type (2011-2016)
Figure United States Immuno-modulatory Biomaterial Sales Growth Rate by Type (2011-2016)
Table United States Immuno-modulatory Biomaterial Sales by Application (2011-2016)
Table United States Immuno-modulatory Biomaterial Sales Market Share by Application (2011-2016)
Figure United States Immuno-modulatory Biomaterial Sales Market Share by Application in 2015
Table United States Immuno-modulatory Biomaterial Sales Growth Rate by Application (2011-2016)
Figure United States Immuno-modulatory Biomaterial Sales Growth Rate by Application (2011-2016)
Table Biomet, Inc. (US) Basic Information List
Table Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biomet, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Bioventus LLC (US) Basic Information List
Table Bioventus LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bioventus LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table DePuy Synthes Companies (US) Basic Information List
Table DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Synthes Companies (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table DePuy Spine, Inc. (US) Basic Information List
Table DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table DePuy Spine, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Exactech, Inc. (US) Basic Information List
Table Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Exactech, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Histogenics Corp. (US) Basic Information List
Table Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Histogenics Corp. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Basic Information List
Table Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Integra LifeSciences Holdings Corp (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table LifeCell Corporation (US) Basic Information List
Table LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeCell Corporation (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table LifeNet Health, Inc. (US) Basic Information List
Table LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table LifeNet Health, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Medtronic, Inc. (US) Basic Information List
Table Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medtronic, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table NovaBone Products LLC (US) Basic Information List
Table NovaBone Products LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovaBone Products LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table NuVasive, Inc. (US) Basic Information List
Table NuVasive, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table NuVasive, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Orthofix International N.V. (Netherlands) Basic Information List
Table Orthofix International N.V. (Netherlands) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Orthofix International N.V. (Netherlands) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Osiris Therapeutics, Inc. (US) Basic Information List
Table Osiris Therapeutics, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Osiris Therapeutics, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Smith & Nephew Plc (UK) Basic Information List
Table Smith & Nephew Plc (UK) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Smith & Nephew Plc (UK) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Stryker Corporation (US) Basic Information List
Table Stryker Corporation (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Stryker Corporation (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table TiGenix N.V. (Belgium) Basic Information List
Table TiGenix N.V. (Belgium) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table TiGenix N.V. (Belgium) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Wright Medical Technology, Inc. (US) Basic Information List
Table Wright Medical Technology, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wright Medical Technology, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table BioMimetic Therapeutics LLC (US) Basic Information List
Table BioMimetic Therapeutics LLC (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMimetic Therapeutics LLC (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Zimmer Holdings, Inc. (US) Basic Information List
Table Zimmer Holdings, Inc. (US) Immuno-modulatory Biomaterial Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zimmer Holdings, Inc. (US) Immuno-modulatory Biomaterial Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-modulatory Biomaterial
Figure Manufacturing Process Analysis of Immuno-modulatory Biomaterial
Figure Immuno-modulatory Biomaterial Industrial Chain Analysis
Table Raw Materials Sources of Immuno-modulatory Biomaterial Major Manufacturers in 2015
Table Major Buyers of Immuno-modulatory Biomaterial
Table Distributors/Traders List
Figure United States Immuno-modulatory Biomaterial Production and Growth Rate Forecast (2016-2021)
Figure United States Immuno-modulatory Biomaterial Revenue and Growth Rate Forecast (2016-2021)
Table United States Immuno-modulatory Biomaterial Production Forecast by Type (2016-2021)
Table United States Immuno-modulatory Biomaterial Consumption Forecast by Application (2016-2021)


More Publications